Zusammenfassung
Die in den letzten Jahren beobachtete weltweite deutliche Zunahme der malignen Melanome betrifft vor allem Erwachsene. Der Gipfel der Erkrankungshäufigkeit liegt zwischen dem 40. und 60. Lebensjahr. Als eine wahrscheinliche Ursache dafür wird die im Vergleich zu früheren Generationen viel stärkere UV-Exposition der jetzt Erwachsenen in der Kindheit und Jugend diskutiert [11]. In einigen Staaten scheint sich die Inzidenz allerdings zu stabilisieren [21]. In der Kindheit selbst können sich während dieser Altersphase solche tumorinduzierenden Faktoren naturgemäß noch kaum auswirken. Die Tumorentwicklung erfordert Zeit [28]. Dementsprechend treten maligne Melanome auch heute unterhalb des 20. Lebensjahres selten auf, sie machen ungefähr 1–3% aller Tumoren im Kindesalter und nur ungefähr 1% aller malignen Melanome aus. Nach dem Schrifttum hat ihre Inzidenz nicht zugenommen [3, 44].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Alper JC (1985) Congenital nevi: The controversy rages on. Arch Dermatol 121: 734–735.
Bahmer FA (1986) Measurement and figure in dermatology. Arch Dermatol 122: 501.
Berg P, Lindelöf B (1997) Differences in malignant melanoma between children and adolescents. Arch Dermatol 133: 295–297.
Boddie AW Jr, Smith JL, McBride CM (1978) Malignant melanoma in children and young adults: effect of diagnostic criteria on staging and results. South med J 71: 1074–1078.
Castilla EE, Dutra MDG, Orioli-Parreiras IM (1981) Epidemiology of congenital pigmented naevi: I. Incidence rates and relative frequencies. Br J Dermatol 104: 307–315.
Davidoff AM, Cirrincione C, Hilliard F, Seigier F (1994) Malignant melanoma in children. Ann Surg Oncol 1: 278–282.
Elder DE (1985) The blind men and the elephant: Different views of small congenital nevi. Arch Dermatol 121: 263–265.
English JSC, Swerdlow AJ (1987) The risk of malignant melanoma, internal malignancy and mortality in xeroderma pigmentosum patients. Br J Dermatol 117: 457–461.
Fish J, Smith EB, Canby JP (1966) Malignant melanoma in childhood. Surgery 59: 309–315.
Gallagher RP, McLean DI, Yang CP, Coldman AJ, Silver HKB, Spinelli JJ, Beagrie M (1990) Anatomic distribution of acquired melanocytic nevi in white children. A com-parison with melanoma: The Vancouver mole study. Arch Dermatol 125: 466–471.
Garbe C (1992) Sonne und malignes Melanom. Hautarzt 43: 251–257.
Gari LM, Rivers JK, Kopf AW (1988) Melanomas arising in large congenital nevocytic nevi: A prospective study. Pediatr Dermatol 5: 151–158.
Goldstein AM, Fräser MC, Clark WH, Tucker MA (1994) Age at diagnosis and transmission of invasive melanoma in 23 Families with cutaneous malignant melanoma/ dysplastic nevi. J Natl Cancer Inst 86: 1385–1390.
Greeley PW (1965) Incidence of malignancy in giant pigmented naevi. Plast Reconstr Surg 36: 26–37.
Greene MH, Clark WH Jr, Tucker MA, Kraemer KH, Elder DE, Fräser MC (1985) High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med 102: 458–465.
Halpern AC, Du Pont Guerry IV, Eider DE, Clark WH, Synnestvedt M, Norman S, Ayerle R (1991) Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. Arch Dermatol 127: 995–999.
Holly EA, Kelly JW, Shpall SN, Chiù SH (1987) Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 17: 459–468.
Hundeiker M (1987) Diagnose und Therapie der kongenitalen Pigmentzellnaevi. Dtsch med Wschr 112: 807–809.
Illig L, Weidner F, Hundeiker M, Gartmann H, Biess B, Leyh F, Paul E (1985) Congenital Nevi 10 cm as precursors to melanoma: 52 cases, a review, and a new conception. Arch Dermatol 121: 1274–1281.
Kaplan EN (1974) The risk of malignancy in large congenital naevi. Plast Reconstr Surg 53: 421–428.
Katsambas A, Nicolaidou E (1996) Cutaneous malignant melanoma and sun exposure. Recent developments in epidemilogy. Arch Dermatol 132 (4): 444–450.
Keipert JA (1985) Giant pigmented naevus: the frequency of malignant change and indications for treatment in prepubertal children. Aust J Dermatol 26: 81–85.
Konz B (1980) Melanome im Kindesalter. Dermatologia 161: 62–73.
Kopf AW, Bart RS, Hennessey P (1979) Congenital nevocytic nevi and malignant melanomas. J Am Acad Dermatol 1: 123–130.
Kraemer KH, Greene MH, Tarone R, Elder DE, Clark WH Jr, Guerry DN (1983) Dysplastic naevi and cutaneous melanoma risk. Lancet 2: 1076–1077.
Kraemer KH, Lee MM, Scotto J (1987) Xeroderma pigmentosum: cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch Dermatol 123: 241–250.
Lartigau E, Spatz A, Avril MF, Bailly C, Lemerle J, Terrier-Lacombe MJ, Margulis A, Prade M (1995) Melanoma arising de novo in childhood: experience of the Gustave-Roussy-Institute. Melanoma Res 5: 177–122.
Lippold A, Hundeiker M (1991) Alter und Tumordicke bei Melanompatienten. Z. Hautkr. 66 (7): 639–640.
MacKie RM, Watt D, Doherty V, Aitchison T (1991) Malignant melanoma occuring in those aged under 30 in the west of Scotland 1979–1986: a study of incidence, clinical features, pathological features and survival. Br J Dermatol 124: 560–564.
Melnik MK, Urdaneta LF, Al-Jurf AS, Foucar E, Jochimsen PR, Soper RT (1986) Malignant melanoma in childhood and adolescence. Am Surg 52: 142–147.
Moss ALH, Briggs JC (1986) Cutaneous malignant melanoma in the young. Br J Plast Surg 39: 537–541.
Müller RPA, Hundeiker M (1991) Congenitale Pigmentzellnaevi-Therapiekonzepte. In: Meigel W (Hrsg.): Diagnostik und Therapie maligner Melanome. Diesbach Verlag, Berlin S 21–29.
Naasan A, Al-Nafussi, A, Quaba A (1996): Cutaneous malignant melanoma in children and adolescents in Scotland, 1979–1991. Plast Reconstr Surg 98: 442–446.
Novakovic B, Clark WH Jr, Fears TR, Fraser MC, Tucker MA (1995) Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families. J Am Acad Dermatol 33 (4): 631–636.
Pers M (1963) Neavus pigmentosus giganticus: Indikationer for operative behandling. Ungeskr Laeger 125: 613–619.
Potter JF, Schoeneman M (1960): Metastasis of maternal cancer to the placenta and fetus. Cancer 25: 392–397.
Quaba AA, Wallace AE 1986) The incidence of malignant melanoma (0 to 15 years of age) arising in “large” congenital nevocellular nevi. Plast Reconstr Surg 78: 174–179.
Rampen FHJ, van der Meeren HLM, Boezeman JBM (1986) Frequency of moles as a key to melanoma incidence? J Am Acad Dermatol 15: 1200–1203.
Rao BN, Hayes FA, Pratt CB, Fleming ID, Kumar APM, Lobe T, Dilawari R, Meyer W, Parham D, Custer MD (1990): Malignant melanoma in children: its management and prognosis. J Pediatr Surg 25 (2): 198–203.
Reed WB, Becker SW Sr, Becker SW Jr, Nickel WR (1965) Giant pigmented naevi, melanoma, and leptomenigeal melanocytosis. Arch Dermatol 91: 100–119.
Reintgen DS, Vollmer R, Seigier HF (1989) Juvenile malignant melanoma. Surg Gynecol Obstet 168: 249–253.
Rhodes AR (1986) Melanocytic precursors of cutaneous melanoma. Estimated risks and guidelines for management. Med Clin North Am 70: 3–37.
Rhodes AR, Sober AJ, Day CL, Meiski JW, Harrist TJ, Mihm MC, Fitzpatrick TB (1982): The malignant potential of small congenital nevocellular nevi: an estimate of association based on a histological study of 234 primary coutaneous melanomas. J Am Acad Dermatol 6: 230–241.
Ruiz-Maldonado R, Orozco-Covarrubias M (1997): Malignant melanoma in children. Arch Dermatol 133: 363–371.
Spatz A, Ruiter D, Hardmeier T, Renard N, Wechsler J, Bailly C, Avril MF, Kwee H, Bastian BC, Hill C, De Potter C, Prade M (1996): Melanoma in childhood: an EORTC-MCG multicenter study on the clinico-pathological aspects. Int J Cancer 68 (3): 317–324.
Swerdlow AJ, English J, MacKie RM (1986) Benign melanocytic moles as a risk factor for malignant melanoma. Br Med J 292: 1555–1559.
Tate PS, Ronan SG, Feucht KA, Eng AM, Das Gupta TK (1993) Melanoma in childhood and adolescence: clinical and pathological features of 48 cases. J Pediatr Surg 28: 217–222.
The management of congenital nevocytic nevi [Symposium] (1984) Pediatr Dermatol 2: 143–156.
Tucker MA, Crutcher WA, Hartge P, Sagebiel RW (1993) Familial and cutaneous features of dysplastic nevi: a case-control study. J Am Acad Dermatol 28: 558–564.
Walton RG, Jacobs AH, Cox AJ (1976) Pigmented lesions in newborn infants. Br J Dermatol 95: 389–396.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Jansen, A., Hundeiker, M. (1999). Maligne Melanome in Kindheit und Jugend. In: Rompel, R., Petres, J. (eds) Operative onkologische Dermatologie. Fortschritte der operativen und onkologischen Dermatologie, vol 15. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60048-7_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-60048-7_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64233-3
Online ISBN: 978-3-642-60048-7
eBook Packages: Springer Book Archive